Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 2, 2003, Pages 452-464

  Varlotto, John M ^a,b   Flickinger, John C ^a   Niranjan, Ajay ^a   Bhatnagar, Ajay K ^a   Kondziolka, Douglas ^a   Lunsford, L Dale ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Brain metastases; Long term results; Radiosurgery

Indexed keywords

BRAIN; CELLS; RADIOTHERAPY; TOXICITY; TUMORS;

BREAST CANCER;

ONCOLOGY;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; CANCER CONTROL; CHILD; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GAMMA KNIFE RADIOSURGERY; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; TUMOR VOLUME;

EID: 0041381154     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00568-6     Document Type: Article

References (43)

1. Alexander E, III, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995;87:34-40.
2. Patchell R. Brain metastases. Handbook Neurol. 25:1997;135-147.
3. Wen P.Y., Loeffler J.S. Management of brain metastases. Oncology. 13:1999;941-961.
4. Pickren J.W., Lopez G., Tzukada Y., et al. Brain metastases An autopsy study . Cancer Treat Symp. 2:1983;295-313.
5. Wen P., Black P.M., Loeffler J.S. Metastatic brain cancer. DeVita V.T., Hellman S., Rosenberg S.A. Cancer principles and practice of oncology . 6th ed. 2001;2655-2670 Lippincott, Williams & Wilkins, Philadelphia.
6. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 322:1990;494-500.
7. Kondziolka D., Patel A., Lunsford L.D., et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 45:1999;427-434.
8. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., et al. The choice of treatment of single brain metastases should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 29:1994;711-717.
9. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 78:1996;1470-1476.
10. Auchter R.M., Lamond J.P., Alexander E., et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 35:1996;27-35.
11. Rutigliano M.J., Lunsford L.D., Kondziolka D., et al. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 37:1995;445-453.
12. Sperduto P, Scott C, Andrews D, et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in brain metastases patients: report of Radiation Therapy Oncology Group phase III study 95-08. Proceedings of the American Society for Therapeutic Radiation and Oncology (ASTRO) [Abstract]. New Orleans, LA. Int J Radiat Oncol Biol Phys. In Press.
13. Mehta M.P., Rozental J.M., Levin A.B., et al. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys. 24:1992;619-625.
14. Kihlstrom L., Karlsson B., Lindquist C. Gamma knife surgery for cerebral metastases Implications for survival based on 16 years experience . Stereotact Funct Neurosurg. 61:(Suppl. 1):1993;45-50.
15. Joseph J., Adler J.R., Cox R.S., et al. Linear accelerator-based stereotaxic radiosurgery for brain metastases The influence of number of lesions on survival . J Clin Oncol. 14:1996;1085-1092.
16. Shiau C.Y., Sneed P.K., Shu H., et al. Radiosurgery for brain metastases relationship of dose and pattern of enhancement to local control . Int J Radiat Oncol Biol. 37:1997;375-383.
17. Pirzkall A., Debus J., Lohr F., et al. Radiosurgery alone or in combination with whole-brain radiotherapy alone. J Clin Oncol. 16:1998;3563-3569.
18. Cho K.H., Hall W.A., Gerbi B.J., et al. Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neurooncol. 40:1998;73-86.
19. Sansur C.A., Chin L.S., Ames J.W., et al. Gamma knife radiosurgery for the treatment of brain metastases. Stereotact Funct Neurosurg. 74:2000;37-51.
20. Maor M.H., Dubey P., Tucker S., et al. Stereotactic radiosurgery for brain metastases Results and prognostic factors . Int J Cancer. 90:2000;157-162.
21. Nakagawa K., Tago M., Terahara A., et al. A single institutional outcome analysis of gamma knife radiosurgery for single or multiple brain metastases. Clin Neurol Neurosurg. 102:2000;227-232.
22. Simonova G., Liscak R., Novotny J., et al. Solitary brain metastases treated with Leksell Gamma Knife Prognostic factors with patients . Radiother Oncol. 57:2000;207-213.
23. Kim D.G., Chung H.T., Gwak H.S., et al. Gamma knife radiosurgery for brain metastases Prognostic factors for survival and local control . J Neurosurg. 93:(Suppl. 3):2000;23-29.
24. Becker G., Jeremic B., Engel C., et al. Radiosurgery for brain metastases The Tuebingen experience . Radiother Oncol. 62:2002;233-237.
25. Flickinger J.C., Kondziolka D., Lunsford L.D., et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys. 46:2000;1143-1148.
26. Gaspar L., Scott C., Rotman M., et al. Recursive partition analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 37:1997;745-751.
27. Lesser G.J. Chemotherapy of cerebral metastases from solid tumors. Neurosurg Clin North Am. 7:1996;527-536.
28. Kristensen C.A., Kristjansen P.E., Hansen H.H. Systemic chemotherapy of brain metastases from small-cell lung cancer A review . J Clin Oncol. 10:1992;1452-1498.
29. Franciosi V., Cocconi G., Michiara M., et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast cancer, nonsmall cell carcinoma, or malignant melanoma A prospective study . Cancer. 85:1999;1599-1605.
30. Boogerd W., Dalesio O., Bais E.M., et al. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer. 69:1992;972-980.
31. Eberhardt W., Wilke H., Stamatis G., et al. Pre-operative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer Mature results of a phase II trial . J Clin Oncol. 16:1998;622-634.
32. Edwards M.J., Walker R., Vinnicombe S., et al. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol. 12:2001;1327-1329.
33. Lyass O., Lossos A., Hubert A., et al. Cisplatin-induced non-convulsive encephalopathy. Anticancer Drugs. 9:1998;100-104.
34. Luppi G., Zoboli A., Barbieri F., et al. ., for the INTACC (Intergruppo Nazionale Terpia Adjuvante Colon Carcinoma). Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer A report of two cases and review of the literature . Ann Oncol. 7:1996;412-415.
35. Ahles T.A., Saykin A. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest. 19:2001;812-820.
36. Patchell R.A., Tibbs P.A., Regine W.F., et al. Post-operative radiotherapy in the treatment of single metastases to the brain A randomized trial . JAMA. 280:1998;1485-1489.
37. Zimm S., Wampler G.L., Stablein D., et al. Intracerebral metastases in solid-tumor patients Natural history and results from treatment . Cancer. 48:1981;384-394.
38. Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases Final results of the first two studies by the Radiation Therapy Oncology Group . Int J Radiat Oncol Biol Phys. 6:1980;1-9.
39. Murray K.J., Scott C., Greenberg H.M., et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases A report of the Radiation Therapy Oncology Group (RTOG) 9104 . Int J Radiat Oncol Biol Phys. 39:1997;571-574.
40. Viala J., Vanel D., Meingan P., et al. Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging Preliminary results in brain metastases . Radiology. 212:1999;755-759.
41. Shaw E., Scott C., Baldassarre S.B., et al. Survival improvement with RSRS13 plus cranial radiation therapy in patients with brain metastases Comparison to the Radiation Therapy Oncology Group recursive partition analysis brain metastases database . J Clin Oncol. 21:2003;2364-2371.
42. Vijayalaxmi Thomas Jr, Reiter R.J., et al. Melatonin From basic research to cancer treatment clinics . J Clin Oncol. 20:2002;2575-2601.
43. Antonadou D., Paraskevaidis M., Sarris G., et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol. 20:2002;3644-3650.